ArticleVaccine: X2023

Comparison of antibody responses following natural infection with Severe Acute Respiratory Syndrome Coronavirus 2 or receipt of CoronaVac or ChAdOx1 (AZD1222) vaccination in Chiang Mai, Thailand.

Sayamon Hongjaisee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.